Ann Allergy Asthma Immunol
Agammaglobulinaemia Tyrosine KinaseAgammaglobulinemiaB-Lymphocytes
Dr. Sergey Devitskiy, MD
NPI1629129747PAC ID5890887517
- Medicare services, 2024
- 602
- Medicare patients, 2024
- 293
- Part D claims, 2024
- 944
- Publications
- 1
- Clinical trials
- 1
- Practice address
- 1 Medical Center Drive, Lebanon, NH 03756
- Practice phone
- Call (603) 650-5000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Devitskiy's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Sergey Devitskiy is a hematologist and oncologist in Lebanon, New Hampshire
Dr. Devitskiy practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.
Dr. Devitskiy's NPI, 1629129747, was assigned on January 16, 2007. Dr. Devitskiy holds New Hampshire license 15405.
NPI and contact details
- NPI
- 1629129747NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5890887517
- NPI enumeration date
- January 16, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (603) 650-5000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 63
- Medical school graduation
- 1989
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Sergey Devitskiy practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire
Dr. Devitskiy's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.
- Dartmouth Hitchcock Medical Center1 Medical Center Drive, Lebanon, NH 03756 · Grafton CountyPhone(603) 650-5000
Source: Dmand AI Affiliation Data
Dr. Sergey Devitskiy is affiliated with 5 sites of care and 3 medical groups
Dr. Devitskiy's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Devitskiy is also affiliated with Cheshire Medical Center. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Devitskiy to 3 more hospitals and 2 medical groups, each named with a free account. Dr. Devitskiy's employer is on file too: a hospital.
Cheshire Medical CenterDartmouth Hitchcock Medical Center3 hospitalsNames with a free account2 medical groupsNames with a free accountEmployer: hospitalName with a free account
See all 8 affiliations for Dr. DevitskiySources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Sergey Devitskiy's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devitskiy practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dartmouth Hitchcock Medical Center | Available with a free account |
| +4 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Devitskiy practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Dartmouth-Hitchcock Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Sergey Devitskiy is one of 67 hematologists and oncologists in New Hampshire
Hematology and oncology is Dr. Devitskiy's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Devitskiy's licenses on file in 2 states: New Hampshire and Massachusetts.
Specialties and state licenses
- Hematology and oncology, New HampshirePrimary
- Internal medicine, Massachusetts
Hematologists and oncologists near Dr. Devitskiy
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
67hematologists and oncologists in New Hampshire19hematologists and oncologists in Lebanon18hematologists and oncologists at Dartmouth Hitchcock Medical Center
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Sergey Devitskiy billed Medicare for 602 services in 2024
CMS data shows 602 Medicare services from Dr. Devitskiy across 5 procedure codes in 2024, for 293 Medicare patients. Medicare paid $51,973 for them.
Medicare services, 2024602
Medicare patients293
Paid by Medicare$51,973
Procedure codes5
Dr. Devitskiy's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 8492024: 58731%
- Other services
- 2023: 02024: 15
Where Dr. Devitskiy's Medicare services took place, 2024
- In an office18731%
- In a facility41569%
Dr. Devitskiy compared with the New Hampshire median for hematologists and oncologists, 2024
- Dr. Devitskiy
- New Hampshire median
- Medicare services
- 602vs 576Close to median
- Medicare patients
- 293vs 24321% above
- Part D claims
- 837vs 2133.9 times
Medians across 65 hematologists and oncologists in New Hampshire with Dmand AI profiles that report each measure.
Dr. Devitskiy's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Devitskiy?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Devitskiy and other hematologists and oncologists in New Hampshire.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Sergey Devitskiy treated 293 Medicare patients in 2024, average age 76
CMS counts 293 Medicare patients who saw Dr. Devitskiy in 2024. The largest group is 75 to 84, with 120 patients. 75% of them have cancer, and 69% have high blood pressure. 8% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Devitskiy's median patient age at 74, with 16% women.
Medicare patients, 2024293
Average age76
Average risk score2.15
Also on Medicaid8%
Dr. Devitskiy's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Devitskiy's Medicare patients by sex, 2024
- Women3010%
- Men26390%
Chronic conditions among Dr. Devitskiy's Medicare patients, 2024
- Cancer75%
- High blood pressure69%
- High cholesterol53%
- Arthritis37%
- Ischemic heart disease26%
- Mood disorders24%
- Atrial fibrillation21%
- Depression21%
Share of Medicare patients with each condition. A patient can have several.
Dr. Devitskiy's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women16%
- Men84%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Sergey Devitskiy wrote 944 Medicare Part D claims in 2024
In 2024, Dr. Devitskiy wrote 944 Medicare Part D claims for 137 patients. 70% of them were for generic drugs. CMS names the drug for 837 of them, across 16 drugs with 11 or more claims each, at $3,786,779 in total drug cost. In 2023, CMS named 862 claims across 12 drugs.
Part D claims, 2024944
Drugs named by CMS16
Total drug cost$3.8M
Part D patients137
Dr. Devitskiy's Part D claims by kind of drug, 2024
- Generic661 claims70%
- Brand-name283 claims30%
Dr. Devitskiy's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 8622024: 8373%
Drugs named by CMS: 16 in 2024, 12 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Sergey Devitskiy offers telehealth to Medicare patients
Dr. Devitskiy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Devitskiy as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Devitskiy by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Sergey Devitskiy has 1 publication on record
Dmand AI links 1 paper to Dr. Devitskiy in 2018. Dr. Devitskiy's most frequent co-authors are Ting-Jia Rosalinda Huang Lorigiano, MD and Alexandra T. Lucas, MD.
Papers1
Dr. Devitskiy's most frequent co-authors
Recent publications by Dr. Devitskiy
See who Dr. Devitskiy researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Devitskiy works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Sergey Devitskiy has worked on 1 clinical trial
Dmand AI links Dr. Devitskiy to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.
Conditions in Dr. Devitskiy's trials
- Prostatic Neoplasms
- Prostatic Diseases
Investigators on the most trials with Dr. Devitskiy
Recent clinical trials with Dr. Devitskiy
CASPAR - a Phase III Trial of Enzalutamide and Rucaparib As a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer (opens in a new tab)
Active, not recruitingPhase 3
Prostatic NeoplasmsProstatic DiseasesEnzalutamideDegarelixGoserelin Acetate
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Sergey Devitskiy received $192 in industry payments from 2022 to 2024
CMS Open Payments shows 5 general payments to Dr. Devitskiy from 3 drug and device companies from 2022 to 2024. Education make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $99.
General payments to Dr. Devitskiy by program year, 2022 to 2024
Companies that paid Dr. Devitskiy the most, 2022 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Sergey Devitskiy's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Sergey Devitskiy
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Sergey Devitskiy's NPI number?
Dr. Sergey Devitskiy's NPI number is 1629129747. It was assigned on January 16, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Sergey Devitskiy?
Dr. Sergey Devitskiy is a hematologist and oncologist in Lebanon, New Hampshire. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Sergey Devitskiy practice?
Dr. Devitskiy practices at 1 Medical Center Drive, Lebanon, NH 03756. Dr. Devitskiy's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dmand AI also links Dr. Devitskiy to 3 hospitals and 2 medical groups.
What is Dr. Sergey Devitskiy's office phone number?
The practice phone on file for Dr. Devitskiy is (603) 650-5000.
What is Dr. Sergey Devitskiy's medical license number?
Dr. Devitskiy holds New Hampshire license 15405, one of the licenses on file in 2 states.
Which states has Dr. Sergey Devitskiy been licensed in?
Dmand AI has state licenses on file for Dr. Devitskiy in New Hampshire and Massachusetts.
Which hospitals is Dr. Sergey Devitskiy affiliated with?
Dr. Devitskiy practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire. Dr. Devitskiy is also affiliated with Cheshire Medical Center. Dmand AI links Dr. Devitskiy to 3 more hospitals.
What medical group is Dr. Sergey Devitskiy part of?
Dr. Devitskiy is linked to Dartmouth Hitchcock Medical Center. Dmand AI links Dr. Devitskiy to 2 more medical groups.
Does Dr. Sergey Devitskiy accept Medicare?
Yes. CMS data shows Dr. Devitskiy billed Medicare for 602 services in 2024, and Dr. Devitskiy accepts Medicare assignment.
Does Dr. Sergey Devitskiy offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Devitskiy as offering telehealth services.
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Sergey Devitskiy see?
CMS counts 293 Medicare patients who saw Dr. Devitskiy in 2024, with an average age of 76.
What services does Dr. Sergey Devitskiy bill to Medicare?
In 2024, Dr. Devitskiy's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and office visit, new patient (99205).
What drugs does Dr. Sergey Devitskiy prescribe most?
In 2024 Medicare Part D data, Dr. Devitskiy's most prescribed drugs by claims were Prednisone, Abiraterone Acetate and Xtandi.
Has Dr. Sergey Devitskiy received payments from drug or device companies?
CMS Open Payments shows $192 in general payments to Dr. Devitskiy from 3 companies from 2022 to 2024. The largest total came from Janssen Pharmaceuticals, Inc.
How long has Dr. Sergey Devitskiy been practicing?
Dr. Devitskiy graduated from medical school in 1989, 37 years ago.
Does Dr. Sergey Devitskiy do research?
Dmand AI links 1 publication to Dr. Devitskiy. Dr. Devitskiy has worked on 1 clinical trial.
Who does Dr. Sergey Devitskiy publish with?
Dr. Devitskiy's most frequent co-authors are Ting-Jia Rosalinda Huang Lorigiano, MD (1 shared paper) and Alexandra T. Lucas, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in New Hampshire by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card